INTERNATIONAL PATENT: SWEDISH ORPHAN BIOVITRUM AG, GIAMARELLOS-BOUBOULIS, EVANGELOS J., ALFANO, SIMON JONAS, JAMIESON, BRIAN DAVID, MONNET, EMMANUEL PIERRE FILES APPLICATION FOR "USE OF EMAPALUMAB FOR TREATMENT"

GENEVA, Nov. 3 -- SWEDISH ORPHAN BIOVITRUM AG (Riehenring 1824058 Basel), GIAMARELLOS-BOUBOULIS, Evangelos J. (c/o Hellenic Institute for the Study of Sepsis88 Michalakopoulou Street1528 Athens), ALFANO, Simon Jonas (c/o Sobi, Inc.77 4th Ave., 3rd FloorWaltham, Massachusetts 02451), JAMIESON, Brian David (c/o Sobi, Inc.77 4th Ave., 3rd FloorWaltham, Massachusetts 02451), MONNET, Emmanuel Pierre (c/o Swedish Orphan Biovitrum AGRiehenring 1824058 Basel) filed a patent application (PCT/EP2025/061363) for "USE OF EMAPALUMAB FOR TREATMENT" on Apr 25, 2025. With publication no. WO/2025/224314, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent ...